fhbg
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2005 (NCT00185848)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Also known as
- fhbg
- fhbg
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03240861 | Phase 1 | Jul 26, 2017 | California Institute for Regenerative Medicine (CIRM), University of California, Los Angeles |
| NCT00185848 | Phase 1 | Apr 1, 2005 | Stanford University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| California Institute for Regenerative Medicine (CIRM) | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Stanford University | Academic/Hospital | 1 | 1 | 1 | 2005 |
| University of California, Los Angeles | Academic/Hospital | 1 | 1 | 1 | 2017 |
3 organizations
Page 1 / 1